These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37770983)

  • 21. Corneal fluorescein staining and ocular symptoms but not Schirmer test are useful as indicators of response to treatment in chronic ocular GVHD.
    Amparo F; Shikari H; Saboo U; Dana R
    Ocul Surf; 2018 Jul; 16(3):377-381. PubMed ID: 29763694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topical proparacaine eye drops to improve the experience of patients undergoing intravitreal injections: A randomized controlled trial.
    Reynolds MM; Mercill SL; Wirkus AL; Greenwood Quaintance K; Pulido JS
    Eur J Ophthalmol; 2020 Nov; 30(6):1454-1460. PubMed ID: 31983237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topical Omega-3 Polyunsaturated Fatty Acids for the Treatment of Dry Eye - Results from a Pilot Randomized Controlled Masked-Observer Study.
    Kaercher T; Messmer EM; Berninger T; Huber-van der Velden KK; Geiger R; Cipriano-Bonvin P; Jacobi C
    Clin Ophthalmol; 2022; 16():4021-4031. PubMed ID: 36523849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypochlorous Acid 0.01% vs Povidone-Iodine 5% for Ocular Antisepsis.
    Hejkal TW; Maloley LA; Kaddoura L
    J Vitreoretin Dis; 2022; 6(2):132-137. PubMed ID: 37008664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lifitegrast ophthalmic solution 5.0% for treatment of dry eye disease: results of the OPUS-1 phase 3 study.
    Sheppard JD; Torkildsen GL; Lonsdale JD; D'Ambrosio FA; McLaurin EB; Eiferman RA; Kennedy KS; Semba CP;
    Ophthalmology; 2014 Feb; 121(2):475-83. PubMed ID: 24289915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of recurrent povidone-iodine usage on conjunctival flora in diabetic patients undergoing intravitreal injections.
    Einan-Lifshitz A; Sorkin N; Smollan G; Barequet I
    Eur J Ophthalmol; 2021 Mar; 31(2):607-611. PubMed ID: 31983226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acupuncture and dry eye: current perspectives. A double-blinded randomized controlled trial and review of the literature.
    Dhaliwal DK; Zhou S; Samudre SS; Lo NJ; Rhee MK
    Clin Ophthalmol; 2019; 13():731-740. PubMed ID: 31114151
    [No Abstract]   [Full Text] [Related]  

  • 28. Assessing the severity of keratitis sicca with videokeratoscopic indices.
    de Paiva CS; Lindsey JL; Pflugfelder SC
    Ophthalmology; 2003 Jun; 110(6):1102-9. PubMed ID: 12799233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dry Eye Disease in Hemifacial Spasm Patients Treated with Botulinum Toxin Type A.
    Jariyakosol S; Uthaithammarat L; Chatwichaikul N; Kasetsuwan N; Chongpison Y
    Clin Ophthalmol; 2021; 15():1775-1782. PubMed ID: 33953536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conjunctival and corneal pneumatic sensitivity is associated with signs and symptoms of ocular dryness.
    Situ P; Simpson TL; Fonn D; Jones LW
    Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):2971-6. PubMed ID: 18390645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced ocular surface disease index (OSDI) scores in patients with isotretinoin treatment.
    Caglar C; Senel E; Sabancilar E; Durmus M
    Int Ophthalmol; 2017 Feb; 37(1):197-202. PubMed ID: 27193123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A 4-week, randomized, double-masked study to evaluate efficacy of deproteinized calf blood extract eye drops versus sodium hyaluronate 0.3% eye drops in dry eye patients with ocular pain.
    Wu Y; Jin X; Mou Y; Yuan K; Min J; Huang X
    Ann Palliat Med; 2021 Apr; 10(4):3617-3625. PubMed ID: 33615815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of botulinum toxin type A on the treatment of dry eye disease and tear cytokines.
    Choi MG; Yeo JH; Kang JW; Chun YS; Lee JK; Kim JC
    Graefes Arch Clin Exp Ophthalmol; 2019 Feb; 257(2):331-338. PubMed ID: 30552510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discomfort symptoms reduction and ocular surface parameters recovery with Artelac Rebalance treatment in mild-moderate dry eye.
    Versura P; Profazio V; Giannaccare G; Fresina M; Campos EC
    Eur J Ophthalmol; 2013; 23(4):488-95. PubMed ID: 23539457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Symptomatic dry eye disease among university students.
    Al-Zubi KM; Al-Kubaisy WA; Al-Azzeh YE; Batayneh BK; Alqaraleh HA; Abid LA; Al-Jadid Al-Majali GO; Alhajaj NT
    Med Hypothesis Discov Innov Ophthalmol; 2023; 12(2):70-77. PubMed ID: 38357613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical antibiotic prophylaxis before intravitreal injections: a pilot study.
    Trovato Battagliola E; Riveros Cabral RJ; Manco G; Puggioni G; Brancato C; Mangiantini P; Testa F; Malvasi M; Raponi G; Turchetti P; Pacella F; Pacella E
    Graefes Arch Clin Exp Ophthalmol; 2023 Oct; 261(10):2953-2959. PubMed ID: 37199800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ocular surface and tear film changes in workers exposed to organic solvents used in the dry-cleaning industry.
    Jiménez Barbosa IA; Rodríguez Alvarez MF; Dussán Torres GA; Khuu SK
    PLoS One; 2019; 14(12):e0226042. PubMed ID: 31815965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and Safety of Single-dose OC-02 (Simpinicline Solution) Nasal Spray on Signs and Symptoms of Dry Eye Disease: The PEARL Phase II Randomized Trial.
    Torkildsen GL; Pattar GR; Jerkins G; Striffler K; Nau J
    Clin Ther; 2022 Sep; 44(9):1178-1186. PubMed ID: 35965109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low ambient temperature correlates with the severity of dry eye symptoms.
    Ho WT; Chiu CY; Chang SW
    Taiwan J Ophthalmol; 2022; 12(2):191-197. PubMed ID: 35813789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Post-injection endophthalmitis rates with reduced povidone-iodine prophylaxis in patients with self-reported iodine sensitivity.
    Mulcahy LT; Schimansky S; Fletcher E; Mohamed Q
    Eye (Lond); 2021 Jun; 35(6):1651-1658. PubMed ID: 32839557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.